Cullinan Associates’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
LP
Cullinan Associates's ZBH Position: Q2 2018 in Review
Cullinan Associates sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 1,906 shares — an estimated $202K sold.
Cullinan Associates first reported a position in ZBH in Q2 2013 and held it in 20 quarters. The position peaked at $4.25M in Q1 2015. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.
- Cullinan Associates reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
- Cullinan Associates sold 1,906 Zimmer Biomet shares in Q2 2018, an estimated $202K.
- Cullinan Associates first reported a position in Zimmer Biomet in Q2 2013 and held it in 20 quarters.
- Cullinan Associates's Zimmer Biomet position peaked at $4.25M in Q1 2015.
- 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.
Based on Cullinan Associates's 13F filing for Q2 2018, filed 9 Jul 2018.